Samlet havde 7% af mRCC- populationen enten kliniske eller laboratoriemæssige tegn på behandlingsprovokeret hypotyreose.
Overall, 7% of the MRCC population had either clinical or laboratory evidence of treatment-emergent hypothyroidism.